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A B S T R A C T
Introduction: Fetal overgrowth is an acknowledged risk factor for abnormal labor course and maternal
and perinatal complications. The objective of this study was to evaluate whether the use of antenatal
ultrasound-based customized fetal growth charts in fetuses at risk for large-for-gestational age (LGA)
allows a better identification of cases undergoing caesarean section due to intrapartum dystocia.
Material and methods: An observational study involving four Italian tertiary centers was carried out.
Women referred to a dedicated antenatal clinic between 35 and 38 weeks due to an increased risk of
having an LGA fetus at birth were prospectively selected for the study purpose. The fetal measurements
obtained and used for the estimation of the fetal size were biparietal diameter, head circumference,
abdominal circumference and femur length, were prospectively collected. LGA fetuses were defined by
estimated fetal weight (EFW) >95th centile either using the standard charts implemented by the World
Health Organization (WHO) or the customized fetal growth charts previously published by our group.
Patients scheduled for elective caesarean section (CS) or for elective induction for suspected fetal
macrosomia or submitted to CS or vacuum extraction (VE) purely due to suspected intrapartum distress
were excluded. The incidence of CS due to labor dystocia was compared between fetuses with EFW >95th
centile according WHO or customized antenatal growth charts.
Results: Overall, 814 women were eligible, however 562 were considered for the data analysis following
the evaluation of the exclusion criteria. Vaginal delivery occurred in 466 (82.9 %) women (435 (77.4 %)
spontaneous vaginal delivery and 31 (5.5 %) VE) while 96 had CS. The EFW was >95th centile in 194 (34.5
%) fetuses according to WHO growth charts and in 190 (33.8 %) by customized growth charts, respectively.
CS due to dystocia occurred in 43 (22.2 %) women with LGA fetuses defined by WHO curves and in 39
(20.5 %) women with LGA defined by customized growth charts (p 0.70). WHO curves showed 57 %
sensitivity, 72 % specificity, 24 % PPV and 91 % NPV, while customized curves showed 52 % sensitivity, 73 %
specificity, 23 % PPV and 91 % NPV for CS due to labor dystocia.
Conclusions: The use of antenatal ultrasound-based customized growth charts does not allow a better
identification of fetuses at risk of CS due to intrapartum dystocia.
© 2020 Elsevier B.V. All rights reserved.
Abbreviations: US, ultrasound; 2D, two-dimensional; 3D, three-dimensional; LGA, large-for-gestational age; CS, caesarean section; EFW, estimated fetal weight; WHO,
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Fetal macrosomia is among the acknowledged risk factors for
intrapartum dystocia and other major complications of labor for
the mother and the fetus which include emergency caesarean
section, postpartum hemorrhage, perineal tears, shoulder dystocia
and hypoxic-ischemic encephalopathy [1,2].
The ultrasound (US) evaluation of the fetal weight either with
two-dimensional (2D) ultrasound (US) [3] or with the more
recently described three-dimensional (3D) US techniques [4–8] is
currently considered the most accurate method for the antenatal
detection of fetal macrosomia, even though US estimation of the
fetal size is known to become increasingly imprecise at the
extremes of the distribution of the estimated fetal weight and
particularly in the setting of suspected fetal overgrowth [9].
Fetal macrosomia has been commonly referred to a birthweight
above the threshold of 4000 g [10]. However, it is widely
acknowledged that fetal macrosomia does not necessarily lead
to cephalo-pelvic disproportion (CPD), which is not determined
only by the fetal size but also by the size and the anatomic features
of the maternal pelvis [11,12].
Based on the assumption that fetal growth pattern may be
subjected to substantial variability related to the race and
constitutional characteristics of the parents, over the last two
decades the use of customized antenatal growth charts has been
proposed in clinical practice with the aim of assessing the specific
growth potential of each fetus and to tailor on this the
management of pregnancy. However, the clinical usefulness of
such approach in improving the pregnancy outcome in still
debated. In particular, there is limited data on the performance of
customized fetal growth charts within the context of suspected
fetal overgrowth and its related complications [13–18]. The aim of
this study was to compare the accuracy of recently implemented
antenatal ultrasound-based customized growth charts [19] with
that of the growth charts developed by the World Health
Organization (WHO) [20] in the identification of LGA fetuses
undergoing caesarean section (CS) due to intrapartum dystocia.
Methods
The study involved five Italian Tertiary Maternity Units
(University Hospitals of Parma, Brescia, Rome Tor Vergata and
Naples Federico II and Burlo Garofolo Hospital, Trieste) between
January 2017 and July 2018. In the involved centres, all patients
with non-anomalous singleton pregnancy and acknowledged risk
factors for fetal macrosomia – which included a medical history of
pregestational diabetes mellitus, obesity, as defined as body mass
index above 30 kg/m [2], or obstetric risk factors such as
gestational diabetes (diagnosed following the Guidelines by the
World Health Organization) [21], previous history of fetal macro-
somia or suspected fetal macrosomia at US or symphysis-to-fundal
height assessment of the fetal growth performed in the third
trimester – were referred to a dedicated antenatal clinic for the
antenatal US estimation of the fetal weight between 35 and 38
weeks of gestation. Pregnancy dating was derived by first trimester
ultrasound. Patients were considered eligible for the study
purposes in the absence of any fetal genetic and structural
abnormality diagnosed either antenatally or postnatally and in the
case of availability of labor and postnatal outcomes.
As per common practice in all the participating referral Fetal
Medicine Units prenatal US examinations follow the 2015 Guide-
lines of the Italian Society on Ultrasound in Obstetrics and
Gynecology (SIEOG) [22]. In all cases the antenatal estimation of
the fetal weight was performed by maternal-fetal medicine
specialists using two-dimensional transabdominal low frequency
probes and the EFW was computed according to the Hadlock IVModel [3], which relies on the combination of the measurements
of the biparietal diameter, head circumference, abdominal
circumference and femur length. Data were prospectively collect-
ed. The EFW percentile was computed according to local charts
which were used for the clinical management of each patient.
For the study purposes, the EFW data obtained from each
Centre were plotted on the antenatal standard growth charts for
the estimation of the fetal weight developed by the WHO [20],
while biometry data as well as maternal and paternal character-
istics were used to calculate the EFW according to the customized
fetal growth charts previously published by the SIEOG [19]. Such
charts are based on cross-sectional US measurements from
uncomplicated singleton pregnancies, accurately dated by
crown-rump length in the first trimester, delivering after 37
weeks’ gestation with known outcome and information available
on maternal and paternal height and weight, parity, and ethnicity
[19]. In details, maternal and paternal characteristics were
included in the algorithm used to obtain customized measure-
ments, while the customized EFW was computed by means of the
Hadlock III model as previously described [23]. Of note, the
absence of any of the covariates included in the customization
algorithm precludes to obtain the customized EFW. The 95th
percentile of the customized growth chart was derived using the
cases from our original manuscript on antenatal ultrasound-based
customized growth charts for singletons [19] and, together with
the 95th percentile of the WHO growth chart, represented the
threshold for the retrospective identification of large-for-gesta-
tional age fetuses (LGA) in the study population. This evaluation
was used only for the study purposes and had no influence on the
clinical management of the patients. As per the aim of the study,
we compared labor and postnatal outcomes in fetuses identified as
LGA according to the WHO charts and those so defined according to
customized charts. In particular, the occurrence of intrapartum
dystocia leading to unplanned caesarean section was compared
between LGA fetuses according to WHO vs customized charts.
Information concerning maternal age, ethnicity, parity, gesta-
tion at the onset of labor and body mass index (BMI) at booking and
at delivery were collected from patient notes and recorded. After
delivery, intrapartum and neonatal outcome data were collected
from patient case notes. Outcome measures included birthweight,
the mode of delivery and a series of variables such as epidural,
augmentation rate, length of labor, postpartum hemorrhage and
third and fourth-degree tear in the mother and birthweight and
birthweight centile corrected for gender and parity according to
the Italian growth charts published by Bertino et al. [24], rate of
shoulder dystocia, APGAR score at 5 min, cord arterial and venous
pH, admission to Neonatal Intensive Care Unit (NICU) for the
neonate. The decision as to whether to deliver due to suspected
intrapartum distress was subjectively defined by the physician in
charge for the patient care based on abnormal CTG tracing
according to FIGO classification system [25], while the decision to
opt for operative delivery due to intrapartum dystocia was based
on the recommendations of the American College of Obstetricians
and Gynecologists for the safe prevention of the primary caesarean
delivery [1]. Deliveries were categorized according to the mode of
delivery in spontaneous vaginal delivery (SVD) and obstetric
intervention by vacuum extractor (VE) or CS, which were further
sub-classified based on the primary indication (i.e. dystocia or
distress).
Cases submitted to elective CS for any indication or to induction
of labor before 39+0weeks due to suspected fetal macrosomia were
excluded from data analysis, as were those diagnosed with failed
induction, whose diagnostic criteria differed across the participat-
ing Centres.
A sample size of 238 patients per group (n = 476 in total) was
planned to compare the primary outcome between the two groups.
Table 2
Demographic features of the included cases.
All cases
N 562
Age (years) mean + SD 32.4 + 5.8
Ethnicity n (%) White (Caucasian, Arabic) 454
(80.5 %)
African 59 (10.7 %)
Asian 38 (6.9 %)
Other (Caribbean, South American,
Mixed) 11 (1.9 %)
Risk factor for fetal macrosomia n (%) DM/GDM + suspected LGA fetus
124 (22.3 %)
DM/GDM + polyhydramnios 4 (0.7
%)
DM/GDM + BMI >30 kg/m2 61
(10.7%)
History of GDM + fetal
macrosomia 5 (0.8 %)
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comparing the incidence of emergency CS in fetuses identified as
LGA by customized vs reference charts [26]. We assumed that the
incidence of unplanned CS for labor dystocia in the control group
(i.e. LGA defined by reference charts) would be 42.7 % and that the
use of customized antenatal growth charts would be associated
with an emergency CS rate increased up to 55.5 %. The sample size
was computed using Power and Sample Size Calculator (Biostatis-
tics Department, Vanderbilt University, Nashville, TN, USA)
considering an 80 % power and a P-value of 0.05.
As per National regulations, ethics approval for this study was
granted by the local ethics committee in all the participating
centers.
Statistical analysis was performed using Statistical Package for
Social Sciences (SPSS) version 20 (IBM Inc., Armonk, NY, USA).
Comparison of normally and non-normally distributed continuous
variables included the T test for independent sample and 2-tailed t-
test and the Mann-Whitney U-test, respectively and data were
shown as mean + standard deviation or as median (range)
accordingly. Categorical variables were reported as number
(percentage) and compared using the Chi-square or Fisher exact
test. Sensitivity, specificity, positive and negative predictive values
(PPV and NPV, respectively), positive and negative likelihood ratios
(LR + and LR-, respectively) for the identification of cases of CS due
to intrapartum dystocia in LGA fetuses identified at reference and
customized charts were evaluated and compared. p < 0.05 wasTable 1
Agreement and disagreement in the identification of LGA fetuses at WHO and customi
Customized <95t
n (%) 
WHO <95th percentile n (%) 349 (62.1 %) 
WHO >95th percentile n (%) 23 (4.1 %) 
Fig. 1. Flow chart (according to STROBE guidelines) [27] for inclusion of cases.considered as statistically significant. This study was reported
according to the STROBE guidelines [27].
Results
Overall, 814 women were eligible over the study period, of
whom 562 were included for the analysis after the evaluation of
the exclusion criteria (Fig. 1).zed growth charts.
h percentile Customized >95th percentile
n (%)
19 (3.4 %)
171 (30.4 %)
BMI >30 kg/m2 179 (32.0%)
Suspected LGA fetus (at US or SFH
assessment) 155 (27.5 %)
History of fetal macrosomia 34
(6.0 %)
Parity n (%) Nulliparae 249 (44.9 %)
BMI at conception (kg/m2) mean + SD 28.2 + 5.8
Term pregnancy BMI (kg/m2) mean + SD 32.2 + 5.2
Gestational age at US examination
(weeks+days) mean + SD
36+5 + 0+6
Estimated fetal weight centile at US
examination (local chart) mean + SD
76.2 + 20.2
Gestational age at delivery (weeks+days)
mean + SD
39+3 + 1+1
Induction of labor n (%) 249 (45.9 %)
Mode of delivery n (%) SVD 435 (77.4 %)
VE 31 (5.5 %)
CS 96 (17.1 %)
Obstetric intervention due to dystocia n
(%)
VE 13 (41.9 %)
CS 76 (79.2 %)
Shoulder dystocia n (%) Yes 4 (0.7 %)
Fetal Gender n (%) Male 316 (56.2 %)
Birthweight (grams) mean + SD 3737 + 474
Birthweight percentile mean + SD 73.0 + 24.5
Umbilical artery pH 7.26 + 0.08
mean + SD
n = 464
Umbilical vein pH 7.34 + 0.07
mean + SD
n=356
Apgar at 5 mins 9 (4–10)
median (range)
n = 554
NICU admission n (%) Yes 8 (1.4 %)
Length of neonatal admission median
(range)
2 (1–17)
US: ultrasound.
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percentile according to WHO charts and 198 (33.8 %) according to
customized curves. In 7.5 % of cases (42/562) the WHO and the
customized charts yielded discordant results in the identification
of LGA (Table 1), with a comparable number of cases that were
classified as LGA only by one chart (4.1 % [23/562] for WHO and 3.4
% [19/562] for customized charts, respectively).
Demographic features and perinatal outcomes of the included
cases are summarized in Table 2. Within our population of 562
fetuses at risk of macrosomia, vaginal delivery occurred in 466
cases (82.9 %), of which 435 (77.4 %) were SVD and 31 VE (5.5 %),
while CS was performed in the remaining 96 cases (17.1 %). In this
latter group, intrapartum dystocia represented the leading
indication 76 cases (79.2 %).
The birthweight was >95th centile in 103 (18.3 %) neonates. Of
these, 66 (64.1 %) and 62 (60.2 %) had been antenatally classified as
LGA at WHO and customized charts, respectively (p = 0.57).
The perinatal outcomes of fetuses identified as LGA according to
WHO and customized antenatal charts are summarized in Tables 3
and 4, respectively. Fetuses identified as LGA at WHO charts
showed significantly lower gestational age at scan (p = 0.01) and at
birth (p < 0.001) and had lower augmentation rate (p = 0.002),
while the frequency of obstetric intervention and CS due to labor
dystocia were significantly higher compared to fetuses with EFW
<95th percentile (p < 0.001 for both), as were the birthweight
(p < 0.001), the birthweight percentile (p < 0.001) and the lengthTable 3
Perinatal outcomes in normal size vs large-for-gestational age fetuses according to WH
EFW 
N 368
Gestational age at US examination (weeks+days) mean + SD 36+6
Gestational age at delivery (weeks+days) mean + SD 39+5
Fetal Gender n (%) Male 
Induction of labor n (%) n = 561 Yes 1
Length of labor (minutes) 283 +
mean + SD
n=446
Mode of delivery n (%) SVD 3
VE 18
CS 47
Mode of delivery – Obstetric intervention due to fetal distress excluded n (%) SVD 3
VE 8 
CS 33
Birthweight (grams) mean + SD 3617 
Birthweight percentile mean + SD 65.9 +
Shoulder dystocia n (%) Yes 3
Augmentation Yes 1
n (%)
n = 476
Epidural Yes 1
n (%)
n = 352
III-IV degree tear n (%) Yes 6
Episiotomy Yes 6
n (%)
n = 548
APGAR 5 < 7 Yes 2
n (%)
n = 554
UA pH 7.26 +
mean + SD
n = 464
UA pH < 7.10 Yes 1
n (%)
n = 464
NICU admission Yes 5
n (%)
N = 523
Length of neonatal admission (days) median (range) 2 (2–
US: ultrasound.of NICU admission (p = 0.003). In fetuses with EFW >95th
percentile according to customized growth charts a significantly
lower gestational age at scan was also noted (p < 0.001);
additionally, a significantly lower gestational age at birth and
augmentation rate were recorded (p < 0.001 for both); finally, the
frequency of obstetric intervention and CS due to labor dystocia
was significantly higher compared to non-LGA fetuses (p = 0.001
and p < 0.001, respectively), as were the birthweight (p < 0.001),
the birthweight percentile (p < 0.001) and the length of the
neonatal admission to NICU (p 0.04).
The results of the paired comparison of the perinatal outcomes
of fetuses identified as LGA at WHO and customized growth charts,
respectively, is shown in Table 5. No differences were found
between the two groups for any of the evaluated demographic and
perinatal outcomes, the rate of obstetric intervention and CS due to
intrapartum dystocia. Sensitivity, specificity, PPV and NPV and
LR + and LR- for the identification of cases of CS due to intrapartum
dystocia in LGA fetuses identified at WHO and customized charts
are summarized in Table 6. Both charts showed low and similar
sensitivity [0.57, 95 % CI (0.45 – 0.68) for WHO charts and 0.52, 95 %
CI (0.40 – 0.64) for customized, respectively] and specificity [0.72,
95 % CI (0.68 – 0.76)) for WHO charts and 0.73, 95 % CI (0.69 – 0.77)
for customized charts], with low PPV [0.24, 95 % CI (0.18 – 0.31) for
WHO charts and 0.23, 95 % CI (0.17 – 0.30) for customized charts]
and LR+ [2.01, 95 % CI (1.57–2.56) and 1.90, 95 % CI (1.47–2.47) for
WHO and customized charts, respectively].O charts.
<95th percentile WHO chart EFW >95th percentile WHO chart p
 N 194
+ 0+5 36+5 + 0+6 0.01
+ 1+0 39+0 + 1+2 <0.01
200 (54.3 %) Male 116 (59.8 %) 0.23
67 (45.5 %) Yes 82 (42.3 %) 0.46
 196 307 + 224 0.24
03 (82.3 %) SVD 132 (68.0 %) <0.01
 (4.9 %) VE 13 (6.8 %)
 (12.8 %) CS 49 (25.2 %)
03 (88.1 %) SVD 132 (73.3 %) <0.01
(2.3 %) VE 5 (2.8 %)
 (9.6 %) CS 43 (23.9 %)
+ 468 3957 + 405 <0.01
 25.9 86.3 + 14.4 <0.01
 (0.8 %) Yes 1 (0.5 %) 0.69
47 (48.7 %) Yes 58 (33.3 %) <0.01
24 (52.8 %) Yes 59 (50.4 %) 0.68
 (1.6 %) Yes 4 (2.1 %) 0.71
5 (18.1 %) Yes 46 (24.5 %) 0.08
 (0.6 %) Yes 1 (0.5 %) 0.96
 0.08 7.25 + 0.08 0.20
3 (4.3 %) Yes 6 (3.7 %) 0.75
 (1.4 %) Yes 3 (1.7 %) 0.82
15) 3 (1–17) <0.01
Table 4
Perinatal outcomes in normal size vs large-for-gestational age fetuses according to customized charts.
EFW <95th percentile customized chart EFW >95th percentile customized chart P
N 372 N 190
Gestational age at scan (weeks+days) mean + SD 36+6 + 0+5 36+4 + 0+6 <0.01
Gestational age at delivery (weeks+days) mean + SD 39+5 + 1+0 38+6 + 1+2 <0.01
Fetal Gender n (%) Male 206 (55.5 %) Male 110 (57.9 %) 0.59
Induction of labor Yes 166 (44.7 %) Yes 83 (43.7 %) 0.81
n (%)
n = 561
Length of labor (minutes) 291 + 202 284 + 226 0.81
mean + SD
n=446
Mode of delivery n (%) SVD 305 (82.0 %) SVD 130 (68.4 %) <0.01
VE 19 (5.1 %) VE 12 (6.3 %)
CS 48 (12.9 %) CS 48 (25.3 %)
Mode of delivery – Obstetric intervention due to fetal distress excluded SVD 305 (86.9 %) SVD 130 (75.6 %) <0.01
VE 10 (2.9 %) VE 3 (1.7 %)
CS 36 (10.2 %) CS 39 (22.7 %)n (%)
Birthweight (grams) mean + SD 3627 + 470 3931 + 415 <0.01
Birthweight percentile mean + SD 66.0 + 25.9 85.8 + 14.5 <0.01
Shoulder dystocia n (%) Yes 4 (1.1 %) Yes 0 (0.0 %) 0.15
Augmentation Yes 152 (49.5 %) Yes 53 (31.4 %) <0.01
n (%)
n = 476
Epidural Yes 123 (52.8 %) Yes 60 (50.4 %) 0.67
n (%)
n = 352
III-IV degree tear n (%) Yes 8 (2.2 %) Yes 2 (1.1 %) 0.35
Episiotomy Yes 67 (18.4 %) Yes 44 (23.9 %) 0.13
n (%)
n = 548
APGAR 5 < 7 Yes 1 (0.3 %) Yes 2 (1.1 %) 0.23
n (%)
n = 554
UA pH 7.26 + 0.09 7.26 + 0.08 0.18
mean + SD
n = 464
UA pH < 7.10 Yes 14 (4.6 %) Yes 5 (3.1 %) 0.43
n (%)
n = 464
NICU admission Yes 4 (1.1 %) Yes 4 (2.3 %) 0.31
n (%)
N = 523
Length of neonatal admission (days) 2 (2–9) 3 (1–17) 0.04
median (range)
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This study has demonstrated that, within a selected population
of pregnant women at risk for fetal macrosomia, the use of
customized growth charts compared to standard growth charts
does not improve the identification of LGA fetuses who eventually
undergo unplanned caesarean section due to intrapartum dystocia.
In our cohort, the performance of WHO and customized growth
charts was similar in terms of identification of LGA fetuses and the
perinatal outcome was also comparable between the two groups.
It is a common ground in obstetrics to assume that the greater
the maternal size the lower the likelihood of obstructed labor,
irrespective of the actual fetal size. Indeed, the available data
suggests a direct relationship between maternal height and size of
the birth canal [28–30]. Furthermore, the use of customized
growth charts allows to correlate the fetal size to maternal (or
parental) characteristics [31–34] and is supposed to define which
is the appropriate biometry of a specific fetus in relation to the
maternal anthropometric features.
On this basis, it seems tempting to speculate that a fetus
appearing large after having adjusted its growth trajectory for
maternal (and/or parental) characteristics is expected to be at
higher risk of caesarean delivery due to obstructed labor. The
background concept is that infants whose size isdisproportionately large for their mothers are at risk of intra-
partum and/or perinatal complications.
On the other hand, the results from our multicentric work
suggest that customized growth charts are unlikely to be helpful in
the prediction of obstructed labor due to CPD nor in the
antepartum identification of cases at higher risk of major perinatal
complications. Differently from what we expected indeed in the
late 3rd trimester the use of Italian customized growth charts built
on algorithms which include a series of parental characteristics
[19] showed identical performances compared to the recent
standard charts developed by the WHO [20]. The decision to adopt
these latter charts as the standard reference for comparison was
shared among the main study investigators and was based on the
robustness and external validity of the data collected by Kiserud
et al. [20]. It is unknown whether the comparison of the
customized Italian charts with different standard growth chart
at 35–37 weeks would have led to different results in terms of
identification of LGA newborns and prediction of CS due to
obstructed labor.
The evaluation of the role of the customized charts in the
identification of fetal overgrowth leading to obstructed labor and
its associated perinatal morbidity has so far yielded contradictory
results in non-selected as well as in populations at risk of fetal
macrosomia. Four studies conducted on non-selected populations
Table 5
Comparison of the perinatal outcomes of fetuses large-for-gestational age fetuses according to WHO versus customized growth charts.
EFW >95th percentile WHO chart EFW >95th percentile customized chart p
N 194 N 190
Gestational age at scan (weeks+days) mean + SD 36+5 + 0+6 36+4 + 0+6 0.54
Gestational age at delivery (weeks+days) mean + SD 39+0 + 1+2 38+6 + 1+2 0.59
Fetal Gender n (%) Male 116 (59.8 %) Male 110 (57.9 %) 0.70
Induction of labor Yes 82 (42.3 %) Yes 83 (43.7 %) 0.78
n (%)
n = 561
Length of labor (minutes) 307 + 224 284 + 226 0.45
mean + SD
n=446
Mode of delivery n (%) SVD 132 (68.0 %) SVD 130 (68.4 %) 0.99
VE 13 (6.8 %) VE 12 (6.3 %)
CS 49 (25.2 %) CS 48 (25.3 %)
Mode of delivery – Obstetric intervention due to fetal distress excluded n (%) SVD 132 (73.3 %) SVD 130 (75.6 %) 0.77
VE 5 (2.8 %) VE 3 (1.7 %)
CS 43 (23.9 %) CS 39 (22.7 %)
Obstetric intervention due to dystocia n (%) Yes 48 (24.7 %) Yes 42 (22.1 %) 0.54
Caesarean section due to intrapartum dystocia n (%) Yes 43 (22.2 %) Yes 39 (20.5 %) 0.70
Birthweight (grams) mean + SD 3957 + 405 3931 + 415 0.72
Birthweight percentile mean + SD 86.3 + 14.4 85.8 + 14.5 0.93
Shoulder dystocia Yes 1 (0.5 %) Yes 0 (0.0 %) 0.32
n (%)
Augmentation Yes 58 (33.3 %) Yes 53 (31.4 %) 0.70
n (%)
n = 476
Epidural Yes 59 (50.4 %) Yes 60 (50.4 %) 0.99
n (%)
n = 352
III-IV degree tear Yes 4 (2.1 %) Yes 2 (1.1 %) 0.43
n (%)
Episiotomy Yes 46 (24.5 %) Yes 44 (23.9 %) 0.90
n (%)
n = 548
APGAR 5 < 7 Yes 1 (0.5 %) Yes 2 (1.1 %) 0.55
n (%)
n = 554
UA pH 7.25 + 0.08 7.26 + 0.08 0.97
mean + SD
n = 464
UA pH < 7.10 Yes 6 (3.7 %) Yes 5 (3.1 %) 0.79
n (%)
n = 464
NICU admission Yes 3 (1.7 %) Yes 4 (2.3 %) 0.69
n (%)
N = 523
Length of neonatal admission (days) 3 (1–17) 3 (1–17) 0.64
median (range)
US: ultrasound.
UA: umbilical artery.
UV: umbilical vein.
NICU: neonatal intensive care unit.
Table 6
Sensitivity, specificity, positive and negative predictive values (PPV and NPV), positive and negative likelihood ratios (LR + and LR-) for the identification of cases of caesarean
section due to intrapartum dystocia in large-for-gestational age (LGA) fetuses identified at WHO and customized charts.
EFW >95th percentile WHO chart EFW >95th percentile customized chart
Sensitivity 0.57, 95 % CI (0.45 – 0.68) 0.52, 95 % CI (0.40 – 0.64)
Specificity 0.72, 95 % CI (0.68 – 0.76) 0.73, 95 % CI (0.69 – 0.77)
PPV 0.24, 95 % CI (0.18 – 0.31) 0.23, 95 % CI (0.17 – 0.30)
NPV 0.91, 95 % CI (0.88 – 0.94) 0.91, 95 % CI (0.87 – 0.93)
LR + 2.01, 95 % CI (1.57–2.56) 1.90, 95 % CI (1.47–2.47)
LR - 1.65, 95 % CI (1.27–2.15) 1.51, 95 % CI (1.19–1.93)
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described algorithm [34] can improve the recognition of LGA
populations at risk of intrapartum morbidity, while Sjaarda et al.
[18] could not demonstrate in this respect a decisive superiority of
customized charts compared with population-based curves.
Similar results were found in studies specifically focused on high
risk populations. Within a selected cohort of pregnanciescomplicated by diabetes, Gonzalez et al. [14] found that the
identification of LGA using customized charts was associated with
a higher incidence of caesarean sections performed due to
intrapartum dystocia, while an earlier study conducted on mothers
affected by gestational diabetes could not demonstrate a better
identification of LGA neonates at risk of adverse perinatal
outcomes compared to population curves [17]. It is important to
A. Dall'Asta et al. / European Journal of Obstetrics & Gynecology and Reproductive Biology 248 (2020) 81–88 87note that in all the aforementioned studies the customized models
were developed based on a previously described algorithm based
on birthweight [34], while the SIEOG customized charts have been
developed from cross-sectional ultrasound measurements [19].
The use of customized fetal growth charts in clinical practice is
still a matter of controversy. Some have suggested a better
performance of the customized approach in the identification of
small fetuses at risk of adverse outcomes compared to different
local, national or international standards [35–38]. Nevertheless,
the rationale behind customized growth charts has been chal-
lenged by the recently implemented international growth stand-
ards published by the Intergrowth consortium and by the World
Health Organization [20,39] and a systematic review of 20 studies
failed to demonstrate the superiority of either method in the
identification of fetuses at risk for adverse perinatal outcome
including mortality [40].
Customization per se represents a mathematic algorithm
designed in order to adjust the fetal growth trajectory on the
basis of the anthropometric characteristics of the parents [19,31–
34]. Regarding the possible usefulness of a customized model in
predicting the occurrence of cephalopelvic disproportion among
LGA infants, the contribution of paternal characteristics is
debatable when not difficult to ascertain. Additionally, the
currently available customized growth models do not take into
account specifically maternal pelvimetry parameters which are
related to the woman size but may have an independent major
impact on the chance of dystocia leading to obstetric intervention.
Among these, a narrow width of the subpubic arch angle (SPA) as a
surrogate of a narrow birth canal has been demonstrated by some
investigators of our group to be independently associated with the
risk of obstructed labor within a selected cohort of nulliparous
women with LGA fetuses [12]; of note, in a recent work by Rizzo
et al. both fetal HC and SPA were found to be independent risk
factors for intrapartum dystocia leading to emergency obstetric
intervention [41]. On this ground, we do envisage that it is
reasonable to hypothesize that the performance of the customiza-
tion in predicting the risk of obstructed labor among LGA fetuses
can be improved by including pelvimetric parameters in the
customization method [18]. Finally, intrapartum fetal head
malpositions and malpresentations also represent a major
determinant of dystocia leading to caesarean section and this
factor is not included – and cannot be included – in any antepartum
customized model aiming at the detection of cases at risk of CPD
[42–45].
To our knowledge, this is the first study evaluating the role
of newly developed ultrasound-derived customized growth
charts [19] in the identification of LGA within a population at
high risk of fetal overgrowth and to compare their perfor-
mance to that of recently implemented standard charts [20].
The prospective design of the data collection together with the
wide patient sample collected and the strict criteria for the
inclusion of the patients are the major strengths of our work.
Moreover, in all included units the US estimation of the fetal
biometry was performed by Fetal Medicine specialists. Finally,
it has to be acknowledged that all the participating centers are
tertiary referral hospitals that use shared and internationally
acknowledged protocol for the management of labor progres-
sion [1]. On the other hand, the fact that each center used
local growth standards for the management of the cases at risk
of fetal macrosomia and that the policy of induction of labor
for suspected macrosomia also differed in the participating
units may represent a limitation, however differences in terms
of management policy across different Centres are not
uncommon in the routine clinical practice. On this basis, 88
cases were excluded due to elective induction of labor for
suspected macrosomia before 39+0 weeks, however we believethat their inclusion would have biased the validity of our
results. Within such context, the paired comparison between
the customized and the WHO standards did not yield any
“subclinical” difference worth to be investigated on a wider
number of cases. Another limitation may be accounted by the
method adopted to obtain the EFW from customized US
measurements, which may have impacted on the effect of
customisation. Furthermore, the decision to use the 95th
percentile as the cut-off value for LGA was arbitrary and based
on the fact that we aimed to identify the fetuses at highest
risk of obstructed labor. Of note, such cut-off value has been
extensively used by several Authors and research groups
[10,46–49] and has recently been suggested to reduce the
likelihood of false-positive cases [47].
In conclusion, our data on a selected cohort of women at risk for
fetal macrosomia suggest that the use of newly developed
ultrasound-derived customized antenatal growth charts does
not improve the identification of LGA infants undergoing intra-
partum caesarean section due to suspected cephalo-pelvic
disproportion. Further research is warranted in order to assess if
the use of customized growth charts specifically focused on the
identification of fetal overgrowth may refine the prediction of the
risk of obstetric intervention due to intrapartum dystocia.
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